Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 21:13:55 UTC, with 32 holding rows worth $515,482,740.

Accession
0001420506-26-002713
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 32 entries on the cover page, a total value of $515,482,740 stated on the cover page (in dollars after the unit check, H1), rows summing to $515,482,740 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR1,998,400$59,252,560dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK7,648,094$52,160,001dollars as filed
JANUX THERAPEUTICS INC47103J105COM2,943,200$50,858,496dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK785,000$47,527,825dollars as filed
ABIVAX SA-00370M103SPONSORED ADS376,794$37,310,142dollars as filed
INSMED INC COM PAR $.01457669307Stock238,088$27,175,364dollars as filed
Boston Scientific Corporation101137107COM550,000$24,007,500dollars as filed
IRHYTHM HOLDINGS INC COM450056106Stock200,980$22,843,387dollars as filed
ALKERMES PLCG01767105SHS550,000$22,286,000dollars as filed
PRIVIA HEALTH GROUP INC74276R102COM1,049,752$20,669,617dollars as filed
MINERALYS THERAPEUTICS INC603170101COM800,000$20,104,000dollars as filed
ZYMEWORKS INC98985Y108COM721,100$19,101,939dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM812,582$15,276,542dollars as filed
KURA ONCOLOGY INC COM50127T109Stock1,275,000$13,655,250dollars as filed
DENALI THERAPEUTICS INC COM24823R105Stock550,700$11,382,969dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW36,400$10,600,772dollars as filed
HEALTHEQUITY INC COM42226A107Stock115,796$10,243,314dollars as filed
BRIDGEBIO PHARMA INC10806X102COM150,000$9,870,000dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock37,000$9,129,380dollars as filed
HUMANA INC COM444859102Stock22,000$8,394,540dollars as filed
ENOVIS CORPORATION194014502COM267,432$4,885,983dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A1,325,570$3,612,178dollars as filed
QUANTERIX CORP74766Q101COMMON STOCK825,000$3,060,750dollars as filed
GENERATE BIOMEDICINES INC370920100COMMON STOCK144,756$2,174,235dollars as filed
AN2 THERAPEUTICS INC037326105COM350,877$1,866,666dollars as filed
PLIANT THERAPEUTICS INC729139105COM1,604,466$1,732,823dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM595,024$1,564,913dollars as filed
REIN THERAPEUTICS INC00887A204COM NEW1,660,197$1,334,798dollars as filed
COYA THERAPEUTICS INC22407B108CMN229,600$1,150,296dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW168,383$1,148,372dollars as filed
IMMUNEERING CORP45254E107CLASS A COM150,000$614,250dollars as filed
ADC THERAPEUTICS SAH0036K147COMMON STOCK399,900$487,878dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-26-002713this filing2026-11-13